ID: h-0ad79cf81a
Hypothesis
Astrocyte-Neuron Lactate Shuttle (H6): Metabolic Coupling Restoration
Astrocyte-specific MCT1 overexpression restores lactate shuttle to re-establish astrocyte-neuron metabolic cross-feeding, sparing neuronal lipids.
🧬 SLC16A1 (MCT1 monocarboxylate transporter 1)🩺 neurodegeneration🎯 Composite 50%💱 $0.52▲1.6%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
Astrocyte-specific MCT1 overexpression restores lactate shuttle to re-establish astrocyte-neuron metabolic cross-feeding, sparing neuronal lipids. Addresses metabolic coupling disruption as upstream driver. Biologically diffuse and too far from development-ready intervention; requires detailed mechanistic characterization.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
graph TD
A["MCT1 transporter dysfunction"] --> B["Astrocyte-to-neuron lactate shuttle failure"]
B --> C["Neuronal glucose starvation despite adequate glucose"]
C --> D["Compromised neuronal lipid homeostasis"]
D --> E["Neuronal vulnerability and dendrite loss"]
E --> F["Cognitive and motor deficits"]⚖️ Evidence
⚖️ Evidence Matrix3 supports3 contradicts
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — SLC16A1
No curated PDB or AlphaFold mapping for SLC16A1 yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for SLC16A1 (MCT1 monocarboxylate transporter 1) from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for SLC16A1 (MCT1 monocarboxylate transporter 1).
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0200
Events (7d)
0
Price History
▲1.6%💾 Resource Usage
LLM Tokens
11,236
$0.0337
Total Cost
$0.0337
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF astrocyte-specific MCT1 is overexpressed via AAV9-GFAP-MCT1 viral vector in 3xTg-AD mice at 6 months of age, THEN we will observe a significant increase in astrocyte-to-neuron lactate flux (measure | A ≥40% increase in neuronal lactate uptake from astrocytes and ≥30% reduction in cortical neuron count loss (caspase-3+ TUNEL+ cells) relative to vector control | — no observation — | pending | 0.65 |
| IF astrocyte-conditional Mct1 knockout (Mct1fl/fl;GFAP-Cre) mice are subjected to MPTP-induced Parkinsonism, THEN these animals will exhibit accelerated dopaminergic neuron loss and increased striatal | ≥50% greater loss of tyrosine hydroxylase+ neurons in substantia nigra pars compacta and ≥2-fold increase in striatal 4-HNE immunoreactivity at 14 days post-MPT | — no observation — | pending | 0.58 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF astrocyte-specific MCT1 is overexpressed via AAV9-GFAP-MCT1 viral vector in 3xTg-AD mice at 6 months of age, THEN we will observe a significant increase in astrocyte-to-neuron lactate flux (measured by 13C-NMR isotopomer analysis) and a corresponding reduction in cortical neuronal loss compared t
Predicted outcome: A ≥40% increase in neuronal lactate uptake from astrocytes and ≥30% reduction in cortical neuron count loss (caspase-3+ TUNEL+ cells) relative to vect
Falsification: No significant difference (p>0.05) in astrocyte-to-neuron lactate transfer or neuronal survival between MCT1 overexpression and control groups, indicating restoration of the lactate shuttle does not m
pendingconf 58%
IF astrocyte-conditional Mct1 knockout (Mct1fl/fl;GFAP-Cre) mice are subjected to MPTP-induced Parkinsonism, THEN these animals will exhibit accelerated dopaminergic neuron loss and increased striatal lipid peroxidation (4-HNE accumulation) compared to Mct1fl/fl littermate controls, confirming that
Predicted outcome: ≥50% greater loss of tyrosine hydroxylase+ neurons in substantia nigra pars compacta and ≥2-fold increase in striatal 4-HNE immunoreactivity at 14 day
Falsification: No significant difference in dopaminergic neuron survival or lipid peroxidation markers between Mct1 knockout and control mice, disproving that MCT1-dependent astrocyte-neuron metabolic coupling is a
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.